Insight Capital Research & Management’s Boston Scientific BSX Stock Holding History

Insight Capital Research & Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-65,649	Closed	-$1.82M	–	104
2017 Q2	$1.82M	Buy	+65,649	New	+$1.74M	1.07%	41
2016 Q4	–	Sell	-68,341	Closed	-$1.63M	–	114
2016 Q3	$1.63M	Sell	68,341 -227,339	-77%	-$5.42M	0.72%	67
2016 Q2	$6.91M	Sell	295,680 -34,215	-10%	-$740K	2.41%	2
2016 Q1	$6.21M	Buy	329,895 +204,543	+163%	+$3.59M	1.92%	9
2015 Q4	$2.31M	Buy	+125,352	New	+$2.25M	0.67%	67

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Insight Capital Research & Management's BSX Position: Q3 2017 in Review

Insight Capital Research & Management sold out of Boston Scientific (BSX) in Q3 2017, closing a stake of 65,649 shares — an estimated $1.82M sold.

Insight Capital Research & Management first reported a position in BSX in Q4 2015 and held it in 5 quarters. The position peaked at $6.91M in Q2 2016. 547 funds tracked by Wall St. Rank hold BSX as of Q3 2017.

Insight Capital Research & Management reported no remaining Boston Scientific position as of Q3 2017 after selling out during the quarter.
Insight Capital Research & Management sold 65,649 Boston Scientific shares in Q3 2017, an estimated $1.82M.
Insight Capital Research & Management first reported a position in Boston Scientific in Q4 2015 and held it in 5 quarters.
Insight Capital Research & Management's Boston Scientific position peaked at $6.91M in Q2 2016.
547 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2017.

Based on Insight Capital Research & Management's 13F filing for Q3 2017, filed 15 Nov 2017.